Private Social Investment


Cancer Foundation

Rido de Janeiro - RJ Other PRONON

This project aims at assessing the safety and efficacy of genetically modified T-lymphocyte therapy (CARs) anti CD19 to treat leukemia and lymphomas, and proposes to develop protocols to generate these cells in vitro, and finally, conduct a pilot study in 8 acute leukemia and lymphoma patients.

8 patients. Amount: R$ 174.558,15